FDA Drops Complaint Over Whoop Blood Pressure Tool After 1-Year Standoff
Updated
Updated · Bloomberg · Jun 23
FDA Drops Complaint Over Whoop Blood Pressure Tool After 1-Year Standoff
2 articles · Updated · Bloomberg · Jun 23
Summary
Tuesday’s reversal lets Whoop keep offering its Blood Pressure Insights feature without threat of FDA enforcement.
The dispute began last July, when the FDA warned that the feature made the Whoop MG tracker a medical device and asked the company to disable it.
Whoop refused to remove the tool and kept negotiating with the regulator, ending an apparent stalemate between the Boston-based company and the agency.